Cargando…

Glucocerebrosidase: Functions in and Beyond the Lysosome

Glucocerebrosidase (GCase) is a retaining β-glucosidase with acid pH optimum metabolizing the glycosphingolipid glucosylceramide (GlcCer) to ceramide and glucose. Inherited deficiency of GCase causes the lysosomal storage disorder named Gaucher disease (GD). In GCase-deficient GD patients the accumu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boer, Daphne E.C., van Smeden, Jeroen, Bouwstra, Joke A., Aerts, Johannes M.F.G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141376/ https://www.ncbi.nlm.nih.gov/pubmed/32182893 http://dx.doi.org/10.3390/jcm9030736

Ejemplares similares

HEPES‐buffering of bicarbonate‐containing culture medium perturbs lysosomal glucocerebrosidase activity
por: van der Lienden, Martijn J. C., et al.
Publicado: (2022)

Consequences of excessive glucosylsphingosine in glucocerebrosidase-deficient zebrafish.
por: Lelieveld, Lindsey T., et al.
Publicado: (2022)

Limitations of drug registries to evaluate orphan medicinal products for the treatment of lysosomal storage disorders
por: Hollak, Carla EM, et al.
Publicado: (2011)

Glycoprotein Non-Metastatic Protein B: An Emerging Biomarker for Lysosomal Dysfunction in Macrophages
por: van der Lienden, Martijn J.C., et al.
Publicado: (2018)

The heat shock protein amplifier arimoclomol improves refolding, maturation and lysosomal activity of glucocerebrosidase
por: Fog, Cathrine K., et al.
Publicado: (2018)

Evaluation of Strategies for Measuring Lysosomal Glucocerebrosidase Activity
por: Ysselstein, Daniel, et al.
Publicado: (2021)

Glucocerebrosidase mutations disrupt the lysosome and now the mitochondria
por: Klein, Andrés D., et al.
Publicado: (2023)

Glucocerebrosidase Mutations alter the endoplasmic reticulum and lysosomes in Lewy body disease
por: Kurzawa-Akanbi, Marzena, et al.
Publicado: (2012)

Stabilization of Glucocerebrosidase by Active Site Occupancy
por: Ben Bdira, Fredj, et al.
Publicado: (2017)

Xylose‐Configured Cyclophellitols as Selective Inhibitors for Glucocerebrosidase
por: Su, Qin, et al.
Publicado: (2021)

Functionalized Cyclophellitols Are Selective Glucocerebrosidase Inhibitors and Induce a Bona Fide Neuropathic Gaucher Model in Zebrafish
por: Artola, Marta, et al.
Publicado: (2019)

Human glucocerebrosidase mediates formation of xylosyl-cholesterol by β-xylosidase and transxylosidase reactions
por: Boer, Daphne E., et al.
Publicado: (2021)

Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease
por: Magalhaes, Joana, et al.
Publicado: (2016)

Synthesis of modified 1,5-imino-d-xylitols as ligands for lysosomal β-glucocerebrosidase
por: Zoidl, Manuel, et al.
Publicado: (2019)

N-Alkylated Iminosugar Based Ligands: Synthesis and Inhibition of Human Lysosomal β-Glucocerebrosidase
por: Wolfsgruber, Andreas, et al.
Publicado: (2020)

Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells
por: McNeill, Alisdair, et al.
Publicado: (2014)

Loss of glucocerebrosidase 1 activity causes lysosomal dysfunction and α-synuclein aggregation
por: Bae, Eun-Jin, et al.
Publicado: (2015)

Design, Synthesis and Structural Analysis of Glucocerebrosidase Imaging Agents
por: Rowland, Rhianna J., et al.
Publicado: (2021)

Lysosome sorting of β-glucocerebrosidase by LIMP-2 is targeted by the mannose 6-phosphate receptor
por: Zhao, Yuguang, et al.
Publicado: (2014)

Loss of β-Glucocerebrosidase Activity Does Not Affect Alpha-Synuclein Levels or Lysosomal Function in Neuronal Cells
por: Dermentzaki, Georgia, et al.
Publicado: (2013)

Parkinsonisms and Glucocerebrosidase Deficiency: A Comprehensive Review for Molecular and Cellular Mechanism of Glucocerebrosidase Deficiency
por: Gatto, Emilia M., et al.
Publicado: (2019)

Improved epidermal barrier formation in human skin models by chitosan modulated dermal matrices
por: Mieremet, Arnout, et al.
Publicado: (2017)

Glucocerebrosidase Mutations Cause Mitochondrial and Lysosomal Dysfunction in Parkinson’s Disease: Pathogenesis and Therapeutic Implications
por: Zheng, Wei, et al.
Publicado: (2022)

Axonal Transport of Lysosomes Is Unaffected in Glucocerebrosidase-Inhibited iPSC-Derived Forebrain Neurons
por: Keefe, A. J., et al.
Publicado: (2023)

Correction: Loss of β-Glucocerebrosidase Activity Does Not Affect Alpha-Synuclein Levels or Lysosomal Function in Neuronal Cells
por: Dermentzaki, Georgia, et al.
Publicado: (2021)

Localization of active endogenous and exogenous β‐glucocerebrosidase by correlative light‐electron microscopy in human fibroblasts
por: van Meel, Eline, et al.
Publicado: (2019)

Lysosomal Enzyme Glucocerebrosidase Protects against Aβ(1-42) Oligomer-Induced Neurotoxicity
por: Choi, Seulah, et al.
Publicado: (2015)

Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology
por: Navarro-Romero, Alba, et al.
Publicado: (2022)

Two phosphatidylinositol 4-kinases control lysosomal delivery of the Gaucher disease enzyme, β-glucocerebrosidase
por: Jović, Marko, et al.
Publicado: (2012)

β-Glucocerebrosidase Deficiency Activates an Aberrant Lysosome-Plasma Membrane Axis Responsible for the Onset of Neurodegeneration
por: Lunghi, Giulia, et al.
Publicado: (2022)

Investigations on therapeutic glucocerebrosidases through paired detection with fluorescent activity-based probes
por: Kallemeijn, Wouter W., et al.
Publicado: (2017)

Glucocerebrosidase and its relevance to Parkinson disease
por: Do, Jenny, et al.
Publicado: (2019)

Targeting neuronal lysosomal dysfunction caused by β-glucocerebrosidase deficiency with an enzyme-based brain shuttle construct
por: Gehrlein, Alexandra, et al.
Publicado: (2023)

LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patients
por: Ysselstein, Daniel, et al.
Publicado: (2019)

Glucocerebrosidase mutations and Parkinson disease
por: Vieira, Sophia R. L., et al.
Publicado: (2022)

Neurological effects of glucocerebrosidase gene mutations
por: Mullin, S., et al.
Publicado: (2018)

Cognitive Functioning of Glucocerebrosidase (GBA) Non-manifesting Carriers
por: Moran, Eileen E., et al.
Publicado: (2021)

Parkinsonism Associated with Glucocerebrosidase Mutation
por: Sunwoo, Mun-Kyung, et al.
Publicado: (2011)

Glucocerebrosidase mutations in primary parkinsonism
por: Asselta, Rosanna, et al.
Publicado: (2014)

Rotenone Blocks the Glucocerebrosidase Enzyme and Induces the Accumulation of Lysosomes and Autophagolysosomes Independently of LRRK2 Kinase in HEK-293 Cells
por: Perez-Abshana, Laura Patricia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7odiv9d4rj9ruj11bfm6tckvf5